DE3780329D1 - Chinoloncarbonsaeure-derivate und ihre herstellung. - Google Patents

Chinoloncarbonsaeure-derivate und ihre herstellung.

Info

Publication number
DE3780329D1
DE3780329D1 DE8787103548T DE3780329T DE3780329D1 DE 3780329 D1 DE3780329 D1 DE 3780329D1 DE 8787103548 T DE8787103548 T DE 8787103548T DE 3780329 T DE3780329 T DE 3780329T DE 3780329 D1 DE3780329 D1 DE 3780329D1
Authority
DE
Germany
Prior art keywords
chinolon
production
acid derivatives
carbonic acid
carbonic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8787103548T
Other languages
English (en)
Other versions
DE3780329T2 (de
Inventor
Kuniyoshi Masuzawa
Saigo Suzue
Keiji Hirai
Takayoshi Ishizaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyorin Pharmaceutical Co Ltd
Original Assignee
Kyorin Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Pharmaceutical Co Ltd filed Critical Kyorin Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE3780329D1 publication Critical patent/DE3780329D1/de
Publication of DE3780329T2 publication Critical patent/DE3780329T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
DE8787103548T 1986-03-17 1987-03-11 Chinoloncarbonsaeure-derivate und ihre herstellung. Expired - Fee Related DE3780329T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61059016A JPS62215572A (ja) 1986-03-17 1986-03-17 キノロンカルボン酸誘導体

Publications (2)

Publication Number Publication Date
DE3780329D1 true DE3780329D1 (de) 1992-08-20
DE3780329T2 DE3780329T2 (de) 1993-03-04

Family

ID=13101068

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787103548T Expired - Fee Related DE3780329T2 (de) 1986-03-17 1987-03-11 Chinoloncarbonsaeure-derivate und ihre herstellung.

Country Status (9)

Country Link
US (1) US4894458A (de)
EP (1) EP0237955B1 (de)
JP (1) JPS62215572A (de)
KR (1) KR940009525B1 (de)
CN (1) CN1019668B (de)
AU (1) AU593873B2 (de)
CA (1) CA1327198C (de)
DE (1) DE3780329T2 (de)
HU (1) HU199453B (de)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU577473B2 (en) * 1985-01-30 1988-09-22 Kyorin Pharmaceutical Co. Ltd. Quinolonecarboxylic acid derivative
JPH0753715B2 (ja) * 1986-02-25 1995-06-07 大塚製薬株式会社 ベンゾヘテロ環化合物
DE3705621C2 (de) * 1986-02-25 1997-01-09 Otsuka Pharma Co Ltd Heterocyclisch substituierte Chinoloncarbonsäurederivate
DE3702393A1 (de) * 1987-01-28 1988-08-11 Bayer Ag 8-cyano-1-cyclopropyl-1,4-dihydro-4-oxo- 3-chinolincarbonsaeuren, verfahren zu ihrer herstellung und diese enthaltende antibakterielle mittel
US5591744A (en) * 1987-04-16 1997-01-07 Otsuka Pharmaceutical Company, Limited Benzoheterocyclic compounds
US5290934A (en) * 1987-04-16 1994-03-01 Otsuka Pharmaceutical Company, Limited Benzoheterocyclic compounds
JPH0794452B2 (ja) * 1987-10-16 1995-10-11 大日本製薬株式会社 新規ピリドンカルボン酸誘導体、そのエステルおよびその塩
IL88003A (en) * 1987-10-16 1992-11-15 Dainippon Pharmaceutical Co Quinoline derivatives,their preparation and pharmaceutical compositions containing them
US5039683A (en) * 1987-10-26 1991-08-13 Pfizer Inc. Azetidinyl quinolone carboxylic acids and esters
US5173484A (en) * 1988-02-05 1992-12-22 Bayer Aktiengesellschaft Quinolone- and naphthyridone carboxylic acid derivatives, process for their production, antibacterial compositions and feed additives containing them
JPH0219377A (ja) * 1988-07-08 1990-01-23 Kyorin Pharmaceut Co Ltd ８‐メチルキノロンカルボン酸誘導体
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
FI95130C (fi) * 1988-07-20 1995-12-27 Sankyo Co Menetelmä lääkeaineena käyttökelpoisten 4-oksokinoliini-3-karboksyylihapon johdannaisten valmistamiseksi
WO1991001308A1 (fr) * 1989-07-21 1991-02-07 Ss Pharmaceutical Co., Ltd. Derives de l'acide quinolonecarboxylique
CA2001203C (en) * 1988-10-24 2001-02-13 Thomas P. Demuth, Jr. Novel antimicrobial dithiocarbamoyl quinolones
EP0997466A1 (de) * 1988-10-24 2000-05-03 PROCTER & GAMBLE PHARMACEUTICALS, INC. Antimikrobielle Laktamchinolone
US5256662A (en) * 1990-04-12 1993-10-26 Warner-Lambert Company Quinolinecarboxylic acid antibacterial agents
US5116834A (en) * 1990-04-12 1992-05-26 Warner-Lambert Company Quinolinecarboxylic acid antibacterial agents
US5047538A (en) * 1990-04-12 1991-09-10 Warner-Lambert Company Quinolinecarboxylic acid antibacterial agents
JPH03115264A (ja) * 1990-08-17 1991-05-16 Otsuka Pharmaceut Co Ltd 抗菌剤
FR2673426B1 (fr) * 1991-03-01 1993-07-16 Bouchara Sa Nouvelles quinolones, leur procede de preparation et les compositions en refermant.
FR2675144B1 (fr) * 1991-04-10 1995-06-16 Bouchara Sa Nouvelles quinolones difluorees - leur procede de preparation et les compositions pharmaceutiques en renfermant.
DE4123918A1 (de) * 1991-07-19 1993-01-21 Bayer Ag 8-vinyl- und 8-ethinyl-chinoloncarbonsaeuren
ES2036136B1 (es) * 1991-10-16 1994-03-01 Inke Sa Procedimiento para la obtencion del acido 1-(2,4-difluorofenil)-6-fluoro-7-(3-metilpiperacinil)-4-oxo-1, 4-dihidroquinolin-3-carboxilico y sus sales.
US5430028A (en) * 1992-05-26 1995-07-04 Ss Pharmaceutical Co., Ltd. 5-aminoquinolone carboxylic acid derivative and antibacterial agent containing the same as active ingredient
FR2692577B1 (fr) * 1992-05-26 1996-02-02 Bouchara Sa Nouvelles quinolones fluorees, leur procede de preparation et les compositions pharmaceutiques en renfermant.
US5527910A (en) * 1992-12-30 1996-06-18 Cheil Foods & Chemicals, Inc. Pyridone carboxylic acid compounds and their uses for treating infectious diseases caused by bacteria
TW252107B (de) * 1993-08-27 1995-07-21 Hokuriku Pharmacetical Co Ltd
DE4342186A1 (de) * 1993-12-10 1995-06-14 Bayer Ag Eintopfverfahren zur Herstellung von 3-Chinoloncarbonsäurederivaten
KR19980701625A (ko) * 1995-01-24 1998-06-25 이토 마사노리 퀴놀린카르본산유도체
US6387928B1 (en) 1997-09-15 2002-05-14 The Procter & Gamble Co. Antimicrobial quinolones, their compositions and uses
HUP0100051A3 (en) 1997-09-15 2002-08-28 Procter & Gamble Antimicrobial quinolones, their compositions and uses
WO2000055116A1 (fr) * 1999-03-17 2000-09-21 Daiichi Pharmaceutical Co., Ltd. Procede de production de derives d'acide 5-amino-8- alkylquinolo necarboxylique, et produits intermediaires intervenant dans la production
US6608078B2 (en) 2000-05-08 2003-08-19 Wockhardt Limited Antibacterial chiral 8-(substituted piperidino)-benzo [i,j] quinolizines, processes, compositions and methods of treatment
US7098219B2 (en) 2000-08-01 2006-08-29 Wockhart Limited Inhibitors of cellular efflux pumps of microbes
US6964966B2 (en) * 2001-04-25 2005-11-15 Wockhardt Limited Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
US6878713B2 (en) * 2001-04-25 2005-04-12 Wockhardt Limited Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
EP1453824A1 (de) * 2001-12-13 2004-09-08 Wockhardt Limited Triple-targeting chirale breitspektrumantimicrobielle piperidino-quinolon-carbonsäurederivate der neuen generation, ihre herstellung, zusammensetzungen und gebrauch als medikamente
US6664267B1 (en) * 2002-05-28 2003-12-16 Wockhardt Limited Crystalline fluoroquinolone arginine salt form
EP1660495B1 (de) * 2003-09-04 2007-07-11 Wockhardt Limited Benzochinolizin-2-carbonsäureargininsalz- tetrahydrat
SI1666477T1 (sl) 2003-09-10 2013-10-30 Kyorin Pharmaceutical Co., Ltd. Derivati 7-(4-substituiran 3-ciklopropilaminometil-1-pirolidinil) kinolonkarboksilne kisline
WO2005111015A1 (ja) 2004-05-13 2005-11-24 Daiichi Pharmaceutical Co., Ltd. 置換ピロリジン誘導体
US20090156577A1 (en) * 2004-09-09 2009-06-18 Benjamin Davis 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
TW200640899A (en) * 2005-01-21 2006-12-01 Daiichi Seiyaku Co Fluoroalkylpyrrolidine derivative
EP1999106B1 (de) 2006-03-28 2012-06-27 TaiGen Biotechnology Co., Ltd. Hybridreduktionsverfahren zur herstellung von chinolon-zwischenverbindungen
MY148393A (en) 2006-03-28 2013-04-15 Taigen Biotechnology Co Ltd Malate salts, and polymorphs of (3s, 5s)-7-[3-amino-5-methyl-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid
BRPI0709220A2 (pt) 2006-03-28 2011-07-12 Procter & Gamble processo de acoplamento para preparo de intermediários de quinolona
JP5322927B2 (ja) * 2007-05-24 2013-10-23 杏林製薬株式会社 １４位置換基に複素芳香環カルボン酸構造を有するムチリン誘導体
US7902227B2 (en) * 2007-07-27 2011-03-08 Janssen Pharmaceutica Nv. C-7 isoxazolinyl quinolone / naphthyridine derivatives useful as antibacterial agents
US8658183B2 (en) * 2007-08-09 2014-02-25 Taigen Biotechnology Company, Ltd. Antimicrobial parenteral formulation
US8188317B2 (en) 2008-12-18 2012-05-29 E. I. Du Pont De Nemours And Company Integrated process for the preparation of polybenzimidazole precursors
US8163961B2 (en) 2008-12-18 2012-04-24 E. I. Du Pont De Nemours And Company Process for the preparation of monomers for polybenzimidazole materials
US8183418B2 (en) 2008-12-18 2012-05-22 E. I. Du Pont De Nemours And Company Process for the synthesis of dihalodinitrotoluene
US8431747B2 (en) 2008-12-18 2013-04-30 E I Du Pont De Nemours And Company Process for the preparation of monomers for polybenzimidazole materials
CN101948389A (zh) * 2010-08-16 2011-01-19 北京颖新泰康国际贸易有限公司 制备2-（5-氟-2，4-二硝基苯氧）乙酸及其酯的方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS604820B2 (ja) * 1979-02-26 1985-02-06 大塚製薬株式会社 キノリンカルボン酸誘導体
JPS5630964A (en) * 1979-08-22 1981-03-28 Kyorin Pharmaceut Co Ltd Novel substituted quinolinecarboxylic acid and its preparation
DE3142854A1 (de) * 1981-10-29 1983-05-11 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-piperazino-chinolin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
US4499091A (en) * 1982-03-31 1985-02-12 Sterling Drug Inc. 1-Amino (or substituted amino)-1,4-dihydro-4-oxo-6-fluoro-7-heterylquinoline-3-carboxylic acids and their use as antibacterial agents
US4665079A (en) * 1984-02-17 1987-05-12 Warner-Lambert Company Antibacterial agents
DE3248506A1 (de) * 1982-12-29 1984-07-05 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7(alkyl-1-piperazinyl)-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
US4473568A (en) * 1983-03-01 1984-09-25 Warner Lambert Company Antibacterial thiazolidine or thiomorpholine substituted quinolines
DE3318145A1 (de) * 1983-05-18 1984-11-22 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
JPS60126271A (ja) * 1983-12-09 1985-07-05 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体
US4571396A (en) * 1984-04-16 1986-02-18 Warner-Lambert Company Antibacterial agents
DE3441788A1 (de) * 1984-11-15 1986-05-15 Bayer Ag, 5090 Leverkusen Alkyl-1-cyclopropyl-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
JPH0635457B2 (ja) * 1985-06-28 1994-05-11 杏林製薬株式会社 ピリドンカルボン酸誘導体およびその製造方法

Also Published As

Publication number Publication date
EP0237955B1 (de) 1992-07-15
HU199453B (en) 1990-02-28
CA1327198C (en) 1994-02-22
HUT43825A (en) 1987-12-28
KR940009525B1 (ko) 1994-10-14
CN1019668B (zh) 1992-12-30
JPS62215572A (ja) 1987-09-22
AU7002687A (en) 1987-09-24
DE3780329T2 (de) 1993-03-04
EP0237955A2 (de) 1987-09-23
CN87101984A (zh) 1987-10-07
KR870008847A (ko) 1987-10-21
EP0237955A3 (en) 1987-11-25
US4894458A (en) 1990-01-16
AU593873B2 (en) 1990-02-22

Similar Documents

Publication Publication Date Title
DE3780329D1 (de) Chinoloncarbonsaeure-derivate und ihre herstellung.
DE3865988D1 (de) Benzoxazol-derivate und ihre herstellung.
ATE89560T1 (de) Makrolid-derivate, ihre herstellung und ihre verwendung.
DE3777366D1 (de) 2,3-dihydro-cumaron-derivate, ihre herstellung und verwendung.
DE3765682D1 (de) Thiolactam-n-essigsaeure-derivate, ihre herstellung und verwendung.
DE3685282D1 (de) Rhombohedrisches polykristallines bornitrid und dessen herstellung.
DE3773722D1 (de) Inosose-derivate und ihre herstellung.
DE3784602T2 (de) Inonos-derivate, ihre herstellung und verwendung.
DE3770020D1 (de) Sulfoxidderivate und ihre herstellung.
DE3382247D1 (de) Vinylcarbonsaeure-derivate, ihre herstellung und verwendung.
DE3774718D1 (de) Benzothiazolylazolidine und ihre herstellung und verwendung.
DE3783751D1 (de) Glyzirrhetinsaeure-derivate und ihre anwendung.
DE3769814D1 (de) Aminozucker-karbonisierungsmittel und ihre herstellung.
DE3884295T2 (de) Säure-Urease und ihre Herstellung.
DE3770013D1 (de) Sulfenamidderivate und ihre herstellung.
DE3681050D1 (de) Desmutagene produkte und ihre herstellung.
DE3774847D1 (de) Trifluorhydroxyaromatische saeure und deren herstellung.
DE3680948D1 (de) Isocyanatverbindungen und ihre herstellung.
DE3770299D1 (de) 1,2,4-triazinonderivate, ihre herstellung und verwendung.
DE3787160D1 (de) Delta-hydroxy-beta-lysin-Derivate und ihre Produktion.
DE3689036T2 (de) Lankacidinderivate und ihre Herstellung.
DE3578557D1 (de) Substituierte thiophen-2-sulfonamide und ihre herstellung.
DE3576078D1 (de) Guanidylfunginderivate und ihre herstellung.
DE3767084D1 (de) Dipropargyloxybenzolverbindungen und ihre herstellung.
DE3481769D1 (de) Cephemderivate und ihre herstellung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee